Open AccessDeceased vs living donor grafts for pediatric simultaneous liver‐kidney transplantation: A single‐center experience
Author(s) -
Gautier Sergey,
Monakhov Artem,
Tsiroulnikova Olga,
Voskanov Mikhail,
Miloserdov Igor,
Dzhanbekov Timur,
Meshcheryakov Sergey,
Latypov Robert,
Chekletsova Elena,
Malomuzh Olga,
Khizroev Khizri,
Dzhiner Deniz,
Pashkova Irina
Publication year - 2020
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.23219
Subject(s) - medicine , single center , transplantation , liver disease , surgery , liver transplantation , kidney , kidney transplantation , stage (stratigraphy) , paleontology , biology
In conditions of limited experience of pediatric simultaneous liver‐kidney transplantation (SLKT) using grafts from living and deceased donors, there is a certain need to validate the approach. Patients The retrospective study of 18 pediatric patients who received SLKT between 2008 and 2019. Results Grafts were obtained from both living and deceased donors. The patients’ age ranged from 2 to 16 years (9 years ±4). The body weight of the children varied from 9.5 to 39 kg (22 kg ±9). The follow‐up period lasted from 1 to 109 months (median 38 months ±35). The various graft combinations were used in both groups. There was no mortality during the follow‐up. There was no significant difference in baseline parameters in recipients who received grafts from living and deceased donors except age (7.5 years ±2.2 vs 11.8 years ±4.1; P = .038). Rate of complications > grade II was higher among recipients of deceased donor SLKT (7.7% vs 60%; OR, 7.8; 95% CI, 1.04‐58.48; P = .044). All the patients are alive with both grafts functioning. All the living donors returned to the normal life. Conclusion SLKT is a safe and effective procedure for children with both simultaneous end‐stage liver disease and end‐stage renal disease. Both living donor partial liver and kidney transplantation and deceased donor liver‐kidney transplantation can be considered as safe and feasible options.